To assess PRDM10 loss of heterozygosity, DNA was isolated from RCC and lipoma tissue from III-4 and from RCC, lung carcinoma and follicular thyroid carcinoma tissue from IV-3. Here, PRDM10 is linked to thyroid gland follicular carcinoma.